DASH Analytics High Definition Care Platform Chosen for CDC Epicenter Trial in Surgical Site Infection
14 August 2018 - 9:07PM
Business Wire
DASH Analytics LLC, makers of the High Definition Care
Platform©, announced today that their machine learning technology
was chosen for a CDC Epicenters Program research trial
entitled "SUpPress SSI – Single Use Negative Pressure Wound Therapy
(NPWT) to Reduce Surgical Site Infections.” The multicenter trial
will assess the efficacy of using negative pressure wound therapy
in preventing surgical site infections.
The DASH platform’s Surgical Site Infection module is a decision
support tool underpinned by powerful machine learning algorithms.
It uses real-time patient data from the electronic medical record
during surgery to determine a patient’s risk of developing a
surgical site infection. The system provides real-time decision
support to surgeons during the operation that allows them to
optimize the wound management strategy to reduce infections. In
previous trials, this technology provided a 74% reduction in
surgical site infections in general surgery, improving patient
outcomes and substantially reducing the cost of care.
The CDC Epicenter trial will use the DASH Surgical Site
Infection module to provide objective, real-time risk
stratification of patients in the operating room for potential
intervention with negative pressure wound therapy. This is a
critical feature of the trial, as the ability of clinicians to
perform such risk stratification is very limited due to the
multitude of complex patient variables that can lead to surgical
site infection.
John W. Cromwell MD, Chief Technology Officer, stated, “We are
very excited that the CDC, through their funding, has endorsed this
innovative approach to reducing infections. We are looking forward
to DASH Analytics being an enabling technology for hospitals to
eliminate infections through real-time data analytics.”
The Surgical Site Infection Module is but one component of the
DASH High Definition Care Platform, a machine learning technology
platform that is designed to use real-time data analytics to
maximize the value of care delivered in hospitals to: 1) improve
patient outcomes, 2) reduce clinical variations in care, and 3)
reduce the costs of hospital care.
About DASH Analytics LLC
DASH Analytics is the developer of the High Definition Care
Platform© (HDCP), a suite of real-time decision support tools that
use state-of-the-art machine learning and prescriptive analytics on
electronic health records and other data sources for optimizing
front-line clinical care. Examples of clinical issues that can be
profoundly impacted by HDCP include surgical site infections, blood
conservation, delirium, and sepsis. The DASH HDCP works with any
EMR system, offering best-in-class technology to accurately predict
outcomes and support appropriate clinical responses. HDCP is
validated on each hospital’s own data to capture unique
characteristics of each institution and its patient population.
HDCP can be flexibly deployed in the provider’s current
workflow.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180814005047/en/
DASH AnalyticsJohn W. Cromwell MD FACS FASCRSChief Technology
Officerjcromwell@dashpredict.com